Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-15-081520)

Filing Details

Accession Number:: 0001209191-15-081520
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-11-20 16:09:24
Reporting Period:: 2015-11-18

Filing Date:: 2015-11-20
Accepted Time:: 2015-11-20 16:09:24
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1215126	G Margaret Mcglynn	C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-11-18	12,500	$57.27	13,588	No	4	M	Direct
Common Stock	Disposition	2015-11-18	12,500	$130.15	1,088	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2015-11-18	12,500	$0.00	12,500	$57.27

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2021-05-11	No	4	M	Direct

Footnotes

Transaction made pursuant to Ms. McGlynn's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $130.15 (range $130.00 to $130.55).
Ms. McGlynn undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Fully vested.